Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14218/JCTH.2017.00009 http://scihub22266oqcxt.onion/10.14218/JCTH.2017.00009 C5606972!5606972!28936407     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Transl+Hepatol 2017 ; 5 (3): 261-71 Nephropedia Template TP {{tp|p=28936407|t=2017. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease |pdf=|usr=}}{{28936407}} gab.com Text Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease JO: J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=28936407 #FOAvip Non-alcoholic fatty liver disease (NAFLD) is a burgeoning global health concern. In the subset of NAFLD patients with non-alcoholic steatohepatitis (NASH), the presence of significant fibrosis at index assessment is associated with poor prognosis and increased mortality. Hence, there is a growing need to accurately assess and stage fibrosis. Liver biopsy, the current gold standard, has limitations with sampling error and is invasive, with associated inherent risk. This has led to a host of non-invasive means of assessing fibrosis, which has garnered relevance in a disease that requires serial assessment of fibrosis longitudinally over time. This review discusses, comprehensively, the various tools available to the clinician for the assessment of fibrosis, including the various scoring systems used in liver biopsy, the non-invasive means of serum biomarkers, such as the highly-validated NAFLD fibrosis score, and the imaging-based modalities, such as transient elastography and magnetic resonance elastography. Twit Text FOAVip Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease ????J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=28936407 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28936407 #FOAvip English Wikipedia <ref>{{Cite pmid|28936407}}</ref> Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease #MMPMID28936407 Cheah MC; McCullough AJ; Goh GBB J Clin Transl Hepatol 2017[Sep]; 5 (3): 261-71 PMID28936407show ga Non-alcoholic fatty liver disease (NAFLD) is a burgeoning global health concern. In the subset of NAFLD patients with non-alcoholic steatohepatitis (NASH), the presence of significant fibrosis at index assessment is associated with poor prognosis and increased mortality. Hence, there is a growing need to accurately assess and stage fibrosis. Liver biopsy, the current gold standard, has limitations with sampling error and is invasive, with associated inherent risk. This has led to a host of non-invasive means of assessing fibrosis, which has garnered relevance in a disease that requires serial assessment of fibrosis longitudinally over time. This review discusses, comprehensively, the various tools available to the clinician for the assessment of fibrosis, including the various scoring systems used in liver biopsy, the non-invasive means of serum biomarkers, such as the highly-validated NAFLD fibrosis score, and the imaging-based modalities, such as transient elastography and magnetic resonance elastography. äCurrent Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver(epmc).pdf DeepDyve Pubget Overpricing